STRESSEconomicGlobal
Eli Lilly is about to report earnings. Here's what to expect
Published:
News summary
Eli Lilly is slated to report third-quarter earnings and revenue, which will likely be fueled by its obesity drug Zepbound and diabetes counterpart Mounjaro.
- Importance
- Low · 24/100
- Impact direction
- Uncertain